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Abstract
Objective
The purpose of this study is to evaluate the relationship between body mass and
depression among Mississippi women with polycystic ovarian syndrome (PCOS).
Methods
Ten women participated in this study. Data was collected by online survey. The
survey was distributed to eligible participants on pcoschallenge.com, a support network
for women with PCOS. The survey included the Center for Epidemiologic Studies
Depression (CES-D) questionnaire as well as five additional questions that asked the
participants to report their weight, height, comorbidities, age, and race. The CES-D score
provided a measurement for depression while the participant’s weight and height allowed
the researcher to calculate body mass index (BMI), the measurement used for body mass.
The participants’ depression scores and BMI scores were analyzed using Pearson’s
correlation coefficient.
Results
With all 10 participants the BMI scores and CES-D scores were negatively
correlated (r = -0.173). The maximum BMI score of 62.02 and the minimum CES-D
score of 8 belonged to the same participant, participant 10. Because participant 10
possessed the maximum BMI and the minimum CES-D score, she could have affected
standard deviation. For experimental purposes the data was analyzed again without
participant 10’s BMI score or CES-D score. Without participant 10’s data, the BMI and
CES-D scores for the remaining nine participants were positively correlated (r = 0.294).
Conclusion
With the inclusion of participant 10’s data, the finding that body mass and
depression were negatively correlated (r = -0.173) does not reflect the findings of past
research. Without participant 10’s data the results were positively correlated (r = 0.294),
which is congruent with the findings of past research (Barry et al., 2011). The findings of
this study are conflicting. In the current study p > 0.05. Therefore, the results are not
clinically significant. Limitations to this study include a small sample size as well as a
lack of representation of individuals without access to the Internet. Future research needs
to be conducted with a larger sample to further examine the relationship between body
mass and depression in women with PCOS.
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Chapter 1
Purpose of the Study
About 5-10% of women worldwide suffer from PCOS, a chronic endocrine
disorder that affects metabolism and fertility. A diagnosis of PCOS includes 2 out of 3
criteria: (1) hyperandrogenism, (2) amenorrhea or oligomennorrhea, and (3) polycystic
ovaries (Shannon & Wang, 2012). Because PCOS affects metabolism, it can cause
distressing and unwanted symptoms such as weight-gain, abdominal obesity and
hirsutism. In addition to causing psychologically disturbing symptoms, PCOS increases
a woman’s risk of developing depression (Coffey & Mason, 2003). To date, no study has
examined a sample of women with PCOS from Mississippi. The aim of this study is to
examine the relationship between body mass and depression among Mississippi women
with PCOS.
PCOS and Depression
In 2000 it was estimated that about 70% of women with PCOS were obese (Lim,
Norman, Davies & Moran, 2013). Ching, Burke, and Stuckey (2007) noted that women
with PCOS not only suffered from obesity, but also from obesity related comorbidities
such as insulin resistance, dyslipidemia, glucose intolerance, and depression. Women
with PCOS did not have to be overweight or obese to experience these comorbidities.
However, having a higher body mass increased the risk of comorbidities such as insulin
resistance, dyslipdemia, glucose intolerance, and depression (Lim, et al., 2013). Body
mass is important to address in women with PCOS because it not only threatens their
physical health, but also their psychological health.
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In addition to experiencing weight gain and obesity related comorbidities, women
with PCOS experienced manifestations of hyperandrogenism including hirsutism, hair
loss, and acne (Shannon & Wang, 2012).

Women with PCOS were more often

concerned with symptoms that affected appearance, such as weight-gain and hirsutism,
than they were with symptoms such as menstrual irregularity or infertility. Furthermore,
decreased health related quality of life was related to symptoms such as acne, hirsutism,
and diabetes mellitus in women with PCOS. This finding suggests that PCOS is just as
psychologically burdening as it is physically (Coffey & Mason, 2003).
The psychological implications of PCOS are evident from the findings of past
research. Women with PCOS were more likely to suffer from depression, psychological
morbidities, and an increased response to stress. Also, women with PCOS reported that
they suffered from low self-esteem, decreased social activity, and decreased romantic
contentment (Coffey & Mason, 2003).
Depression and Increased Body Mass
Being overweight or obese was associated with increased depression, especially
in women with PCOS (Barry, Kuczmierczyk, and Hardiman, 2011). Even after receiving
medical treatment for symptoms, psychological distress persisted in women with PCOS,
causing decreased quality of life. For example, women who were treated for hirsutism
did not experience a decrease in depression (Coffey & Mason, 2003). If these women
were initially treated for depression instead of hirsutism exclusively, perhaps a decrease
in depression would have resulted.
People with a medical illness who suffered from depression had more severe
symptoms of depression and their medical illness. They were also less likely to adapt to

2

their medical illness (Cassano & Favo, 2002). Treating the depression improved the
outcome of any concurrent medical illness (Katon & Ciechhanowski, 2002).
One type of depression, major depressive disorder (MDD) has been found to
cause symptoms such as anhedonia, weight-gain or loss, insomnia or hyperinsomnia,
fatigue or loss of energy, psychomotor retardation, and suicidal ideation. Assessing the
risk of suicide in patients with depression was vital to safety, because a depressed
individual was at an increased risk to harm her self or others (Greenberg, Tesfazion &
Robinson, 2012).
Purpose
Mississippi has one of the highest obesity rates in the country. More than 30% of
the population was classified as obese in 2010 (Majumdar, Morris, Gordon, Kermode,
Forsythe, Herrington, & Iyer, 2010). Women living in Mississippi with PCOS could
potentially be at a higher risk for becoming overweight or obese.

Therefore, it is

important to determine if there is a significant relationship between body mass and
depression in Mississippi women with PCOS so that at-risk populations can be identified.
The psychological profile of women with PCOS needs to be further explored so
that risk factors related to decreased psychological health can be identified. This will
allow healthcare providers to develop a more comprehensive PCOS treatment plan that
addresses both physical and psychological health.
Previous research has been inconsistent regarding the relationship between
obesity and depression. No study found to date has evaluated the relationship between
body mass and depression in Mississippi women with PCOS. This study will attempt to
provide new knowledge that can be utilized by Mississippi healthcare providers when
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assessing and treating women with PCOS. Therefore, this study attempts to answer the
question: What is the relationship between body mass and depression among Mississippi
women with PCOS?
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Chapter II
Literature Review
Past researchers found that many women with PCOS experienced comorbid
conditions related to obesity such as depression and cardiovascular disease (Zhao, Ford,
Dhingra, Strine, & Mokdad, 2009). Studies done in the United States showed that in
2000-2002 about 74% of women with PCOS were obese (Yildiz, Knochenhauer, &
Azziz, 2008). PCOS, while clearly a physiological disease, also affected psychological
health, resulting in a decreased quality of life and a higher risk for depression (Deeks,
Gibson-Helm, & Teede, 2010, Upadhya & Trent, 2003, Himelein & Thatcher, 2006, Li,
Yu Ng, & Stener-Victorin, 2011). Being overweight or obese increased the risk of
developing depression, especially among overweight and obese women with PCOS
(Barry et al., 2011). Increased body mass should be addressed in women with PCOS
because it has been found to affect not only psychological health, but metabolic and
reproductive health as well (Lim et al., 2013).
Impact of Body Mass on PCOS Metabolic and Reproductive Features
Lim, et al. (2013) investigated the effect obesity had on the psychological,
metabolic, and reproductive features of PCOS by extracting data from thirty studies and
comparing the findings. Only three of the thirty studies were conducted in the Americas
so findings may not be entirely representative of women in the United States. Findings
about the effect of obesity on the psychological, metabolic, and reproductive features of
PCOS have been inconsistent in the past, thus this study attempted to further explore the
topic. Lim et al.’s (2013) study provided a better understanding of how increased body
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mass affected the physical features of PCOS, which may have contributed to its
psychological features.
Lim et al. (2013) defined being overweight as having a BMI score of >25 kg/m2
and being obese as having a BMI score of >30 kg/m2.

Asians were considered

overweight with a BMI score of >23 and obese with a BMI score of >25. Adolescent
participants were measured for BMI using age and gender specific Centers for Disease
Control growth charts (85th-95th percentile overweight and >95th percentile obese). BMI
classifications for this study were well defined and accounted for variances in BMI
classification criteria caused by race, gender, and age.
Compared to normal weight women, overweight women with PCOS were found
to have decreased sex hormone binding globulin and increased fasting insulin, fasting
glucose, and triglycerides. No difference was found in total testosterone, hirsutism, total
cholesterol and LDL cholesterol between the two groups (Lim et al., 2013).
Compared to normal weight women, obese women had decreased sex hormone
binding globulin and high-density lipoprotein (HDL) cholesterol, and increased total
testosterone, fasting insulin, total cholesterol, LDL cholesterol, and triglycerides.
Increased fasting insulin, blood glucose, and increased cholesterol levels contributed to
type II diabetes and coronary heart disease, both of which were associated with PCOS
(Ehrmann, Barnes, Rosenfield, Cavaghan, & Imperial, 1999, Legro, 2003). Type II
diabetes and coronary artery disease negatively affected psychological health as well as
contributed to the increased risk for stroke and coronary artery disease in women with
PCOS (de Groot, Dekkers, Romijn, Dieben, & Helmerhorst, 2011, Zhao et al., 2009).
While this study did explore the relationship of body mass and the metabolic,
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reproductive, and psychological features of PCOS, it did not explore the relationship
between the metabolic, reproductive, and psychological features of PCOS.
Cinar, Kizilarslanoglu, Harmanci, Aksoy, Bozdag, Demir, and Yildiz (2011)
conducted a study to explore the relationship between PCOS and depression as well as
the metabolic aspect of PCOS and its effect on depression. This study included 226
participants with PCOS and 85 controls without PCOS who were matched for BMI.
Participants did not take medications for 3 months prior to the test, which ensured more
accurate results as some medications may affect depression (Barry, et al., 2011, Barnard,
Ferriday, Guenther, Strauss, Balen, & Dye, 2007). The Beck Depression Inventory, a
commonly used tool to measure depression, was used. Results concluded that 28.6% of
women with PCOS scored as clinically depressed whereas 4.7% of women without
PCOS scored the same (Cinar et al., 2011). Normal weight and overweight women with
PCOS scored lower on the depression scale than obese women with PCOS.
Cinar et al. (2011) were able to identify a relationship between depression,
postload glucose, insulin resistance and increased lipids. Past researchers had presented
conflicted findings about the correlation between depression and cardiometabolic features
of PCOS. Rasgon, Rao, Hwang, Altshuler, Elman, Zuckerbrow-Milller, & Korenman
(2003) correlated only increased insulin resistance and increased body mass with
depression. Further research needs to be conducted in order to determine the exact
relationship between metabolic features of PCOS and depression. Cinar et al. (2011)
concluded that depression and decreased quality of life in women with PCOS was related
to increased body mass and cardiometabolic features of the disease. Little research has
been done to explore the relationship between body mass and cardiac risk in PCOS.
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Body Mass, Obesity-related Comorbidities and PCOS
De Groot et al. (2011) conducted research to evaluate whether or not obesity
increased the risk of stroke and coronary heart disease in women with PCOS. Five
articles published between 2000 and 2008 were evaluated. Each of the articles compared
women with PCOS to a control group of women without PCOS. Obesity criteria for this
study matched the criteria of the American Medical Association (2010) and WHO’s
(2006) classification of obesity (BMI >30 kg/m2 and a waist circumference of >88 cm).
Results indicated that women with PCOS were twice as likely to develop coronary heart
disease or stroke. After BMI scores were adjusted for demographic factors, there was an
increased risk of 55% (De Groot et al., 2011). While increased body mass may not
necessarily be the cause of coronary heart disease or stroke in a woman with PCOS, it is
important to address increased body mass because it increases a woman’s risk of
depression and decreases her quality of life (Deeks et al., 2010, Himelein & Thatcher,
2006, Li et al., 2011, Upadhya &Trent, 2003, Zhao et al., 2009).
Body Mass and Depression
Zhao et al. (2009) used a telephone survey to involve 177,047 U.S. citizens, 18
years or older, in a study to measure anxiety and depression related to body mass.
Participants were asked about their weight, depression level, possible chronic psychiatric
diagnoses, obesity related comorbidities (diabetes, heart disease, etc.), demographics,
lifestyle factors (smoking, drinking, leisure time, exercise, etc.), and overall general
health.

Few previous studies had been conducted to evaluate how obesity related

comorbidities, lifestyle choices, and psychosocial factors affected mental health in obese
individuals. Since weight was self-reported over the phone in this study, it is possible
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that it was falsely self-reported. In fact, Zhao et al. (2009) reported a 26.0% obesity rate,
which is less than the national obesity rate of 32.2% reported by Ogden, Carroll, Curtin,
McDowell, Tabak, and Flegal (2006).

Thus, the relationship between obesity and

depression may be underreported in this study.
In this study BMI scores were categorized as <18.5 kg/m2 (underweight), 18.5<25 kg/m2 (normal weight), 25-<30 kg/m2 (overweight), 30-<35 kg/m2 (class I obesity),
34-<40 kg/m2 (class II obesity) and >40 kg/m2 (class III obesity), thus this study used
standard categorization of BMI. Demographics including gender were analyzed in this
study. Women who were underweight (<18.5 kg/m2) or overweight or obese (>25) were
more likely to experience depression or have a diagnosis of chronic depression or anxiety
(Zhao et al., 2009).
Results correlating body mass and mental health were determined after
adjustment for other demographic variables, obesity related comorbidities, lifestyle
factors, and overall general health.

Even after adjustment results supported the

established finding that increased body mass is a significant predictor of depression as
well as anxiety (Zhao et al., 2009).
Previous studies have shown that people with diabetes or coronary heart disease
were more likely to suffer from depression (Chiung-Yu, Shu-Ching, Sousa, Chao-Ping, &
Kuei-Ching, 2011). Zhao et al. (2009) found that people with obesity comorbidities such
as diabetes, myocardial infarction, angina pectoris, stroke or asthma were more likely to
have anxiety and depression than those without obesity comorbidities. Zhao et al.’s study
was limited due to the fact that it only evaluated five obesity-related comorbidities while
excluding others (hypertension, gallbladder disease, osteoarthritis, etc.).
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PCOS could be considered an obesity-related comorbidity as up to 74% of women
with PCOS are considered overweight or obese (Yildiz, Knochenhauer, & Azziz, 2008).
Furthermore, PCOS has been linked to obesity-related comorbidities such as stroke,
coronary heart disease and depression (de Groot et al., 2011).
PCOS and Depression
Barry, et al.’s (2011) systematic review and meta-analysis of 12 previous studies
supported former research findings that suggested depression was more common in
women with PCOS than women without PCOS. About 2257 participants were included
in this research (910 with PCOS and 1347 without). Participants were recruited from a
variety of places (med school, friends and family, internet) so the results may have been
influenced by biases (Barry et al., 2011).
Women with PCOS had statistically significant higher rates of depression than
women without PCOS. Barry et al. (2011) suggested that, in clinical terms, this was
comparable to finding that women with PCOS experienced mild depression whereas
women without PCOS experienced no depression. While a difference was found in
depression rates among women who had PCOS versus women who did not have PCOS,
the difference had limited clinical significance. However, 15% of women with PCOS
scored in the moderate to severe depression range (Barry et al., 2011). The psychological
implications of PCOS need to be further addressed as this study showed that some
woman with PCOS might be at higher risk than others.
Barry et al. (2011) also suggested that women with PCOS in their twenties and
thirties were more likely to be depressed than adolescents with PCOS. More research on
adolescents with PCOS needs to be conducted to further explore this finding. Barry et al.
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(2011) did explore how medication, age, and increased body mass could increase the risk
of depression, but it did not explore how lifestyle factors, comorbid conditions, and
demographics affected risk for depression in women with PCOS.
Possible Link Between Decreased Depression and Medication Use in PCOS
Barry et al. (2011) found that women with PCOS taking anti-androgen
medications were less likely to be depressed than women not taking anti-androgen
medications. These results supported the findings of Barnard et al. (2007) but conflicted
with the findings of Rasgon et al. (2003). However, Barry et al. (2011) revealed that each
study used different scales and defined medication use differently so these results should
be carefully interpreted.

The use of medications to treat PCOS and its effect on

depression should be further explored in the future, or participants of studies should at
least identify whether or not they are using medication.
PCOS, Increased Body Mass and Depression
Women with PCOS with increased BMI scores were found to experience higher
rates of depression (Barry et al., 2011). Barry et al. (2011) found that studies that did not
control for BMI had a greater difference of depression levels between the controlled
matches for BMI scores of the PCOS group and the control group. Barry et al. (2011)
stated that this further signified the relationship between increased body mass and
increased depression in women with PCOS.
Notable in reviewing these studies that examined the relationship between BMI,
cardiac risk associated with PCOS, and depression, is the fact that all were conducted
outside the state of Mississippi. To date, studies that sampled Mississippi women have
not been found. Therefore, this research study seeks to address the question, what is the
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relationship between depression and body mass among Mississippi women with PCOS?
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Chapter III
Methodology
Participants
Participant Inclusion Criteria:
1. 21 years of age or older
2. Diagnosis of PCOS from a gynecologist or endocrinologist
3. Currently residing in Mississippi
All women surveyed were members of the online PCOS support group,
pcoschallenge.com, a networking website that provides an online community for women
with PCOS. Because only about 10% of women have PCOS, it was anticipated that
participants would be difficult to encounter in person. With over 21,000 members,
pcoschallenge.com provided access to the desired sample. About 106 women from
Mississippi, who were members of pcoschallenge.com, were invited to participate in the
study. Prospective participants were informed of the inclusion criteria, which was selfreported. Only 10 women chose to participate. Women with chronic diseases were
included in the study due to a low response rate. A control group of healthy individuals
was not used for comparison because the relationship between BMI and depression in
women with PCOS and women without PCOS has been previously compared and well
documented by past research (Deeks et al., 2010, Himelein & Thatcher, 2006, Li et al.,
2011, Upadhya &Trent, 2003, Zhao et al., 2009).
Informed Consent
Because the current study evaluated depression, participants were required to
electronically sign their full name and provide an email address to signify informed
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consent (see Appendix A). This was done to decrease possible risks associated with
depression and to increase safety of the participants. Full disclosure of identity and
contact information allowed the researcher to follow-up with a participant if she scored as
depressed. Participants who scored as depressed were emailed by the researcher and
advised to immediately seek psychological evaluation from a healthcare provider.
Design
This correlational study was conducted to compare BMI and depression in women
with PCOS. Data was obtained by survey (see Appendix B). The study only involved a
one-time data collection. The survey consisted of 25 questions, including the CES-D
questionnaire. It was estimated that the survey would take about 20 minutes to complete.
After the CES-D, five additional questions asked the participant to report her weight,
height, comorbidities, age, and race.

After taking the survey, the participant's

involvement in the research was complete.

Data was analyzed using Pearson’s

correlation coefficient to determine if there is a relationship between body mass and
depression in Mississippi women with PCOS.
Depression Rating Questionnaire
In the current study the CES-D was used to measure depression. The CES-D is a
valid and reliable 20 item questionnaire that scores depressive symptoms on a scale of 060, with a score of > 16 indicating a risk for depressive episodes. The CES-D was
created to evaluate depressive symptoms in the general population (Radloff, 1977).
Using the coefficient alpha, the internal consistency is about .85 for the general
population. In patient samples the internal consistency is about .90. Test reliability is
moderate (.45-.70). The CES-D has been found to be useful in evaluating depressive
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symptoms in specific populations such as patients with spinal cord injuries (Miller,
Anton, & Townson, 2008).
Body Mass Measurement
To measure body mass, BMI was used. BMI is a person’s weight in relation to
height. It is found by dividing weight in kilograms by the square of height in meters or
by dividing weight in pounds by the square of height in inches multiplied by 703.
Because the United States uses customary units, and because participants were asked to
report their weight in pounds and their height in inches, the latter equation was used to
calculate each participant’s BMI. For the purpose of this study BMI scores are classified
as follows: <18.5 kg/m2 (underweight), 18.5-24 kg/m2 (normal weight), 25-29 kg/m2
(overweight), 30-34 kg/m2 (class I obesity), 35-39 kg/m2 (class II obesity) and >40
kg/m2 (class III obesity). The American Medical Association (2010) and WHO (2006)
established these BMI classifications.
Procedures
The survey was created and distributed using qualtrics.com, an online survey
platform. The researcher created a password protected Qualtrics account through the
University of Southern Mississippi to ensure that participant data would be kept secure
and confidential.
Originally, an advertisement to recruit participants was posted to various PCOS
support group websites.

However, this strategy failed to attract participants.

A

modification form was then submitted to the Institutional Review Board of the University
of Southern Mississippi asking if the researcher could individually contact members of
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pcoschallenge.com. After receiving approval (Appendix C), the recruitment document
(see Appendix D) containing a link to the survey was messaged to eligible participants.
The website, pcoschallenge.com allowed the researcher to identify members from
Mississippi by conducting an advanced search by member location. These search results
consisted of a list of members who chose to share their location with others. The terms
“Mississippi” and “MS” were used to search member location. The term “Mississippi”
yielded one search result. The term “MS” yielded 123 search results with only 106 of
those results using “MS” as an abbreviation for “Mississippi”. After eliminating 17
search results in which “MS” did not stand for “Mississippi,” 106 members were invited
to participate.
Survey distribution consisted of personally messaging about 106 members of the
online PCOS support group, pcoschallenge.com. The personal message included a brief
recruitment document, which provided a link to the survey. Participation was completely
voluntary. Informed consent required that the participant disclose her full name as well
as an email address for follow-up purposes.
participants completed the survey.

Over the course of four weeks, five

At the fourth week mark, nonrespondents were

messaged a reminder that the survey was still active. After this reminder five more
participants completed the survey. The survey was available for four weeks and three
days in total.
After data was collected, the researcher scored the participants’ CES-D
questionnaires and calculated the participants’ BMI. If a participant scored as depressed,
she received a follow-up email as previously discussed. Participants’ BMI and CES-D
scores were analyzed using Pearson’s r.
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Power
For the current study to have 75% power a minimum of 77 participants were
needed. With only 10 participants the current study has 8% power.
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Chapter IV
Results
The study included ten participants ranging from 21-54 years of age. Nine
participants identified as white. One participant identified as Hispanic or Latino. Six of
the ten participants reported having been diagnosed with a condition or conditions other
than PCOS. Table 1 provides an overview of the demographics and characteristics of the
participants (n = 10).
Table I
Participant Demographics and Characteristics
Age

Number of participants

21-34

8

35-44

1

45-54

1

Race
White

9

Hispanic or Latino

1

Participants reporting having a
condition(s) other than PCOS
Participants reporting other conditions

6

Participants reporting no other conditions

4

Two participants were classified as normal weight, one participant was classified
as overweight, four participants were classified as class I obese, two participants were
18

classified as class II obese, and one participant was classified as class III obese. Eight
participants were overweight or obese. Five of the ten participants scored > 16 on the
CES-D, indicating that they are at risk for depressive episodes. Table II provides
descriptive statistics for all 10 participants (n = 10).
Table II
Descriptive Statistics (n = 10)
Standard
n

Minimum

Maximum

Mean

(Std.)
Deviation

BMI

10

23.01

62.02

35.7640

11.40096

Depression

10

8.00

33.00

19.1000

9.55045

SD for depression (SD = 9.55045) and to a lesser extent SD for BMI (SD =
11.40096), indicated a large variation among participants. The mean for BMI was
calculated as 35.7640 while the mean for depression was calculated as 19.1000. Note
that the maximum BMI score of 62.02 and the minimum CES-D score of 8 belong to the
same participant, who for the purpose of discussion will be referred to as participant 10.
Because she possesses the maximum BMI score and the minimum CES-D score,
participant 10 could be classified as an outlier affecting SD in this small sample of
participants.
Table III provides results for Pearson’s r correlation with BMI and CES-D scores
from all 10 participants (n = 10). With all 10 participants the BMI scores and CES-D
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scores were negatively correlated (r = -0.173). An r of -0.173 indicates a low correlation
between body mass and depression.
Table III
Correlations (n = 10)

BMI Pearson Correlation

BMI

Depression

1

-0.173

BMI Sig. (2-tailed)

0.633

Depression Pearson

-0.173

1

Correlation
Depression Sig. (2-tailed)

.633

For experimental purposes the data was analyzed again without participant 10’s
BMI score or CES-D score. Table IV provides descriptive statistics excluding participant
10 (n = 9). Without participant 10 the maximum BMI changed to 46.80 and minimum
CES-D score changed to 10.00.
Table IV
Descriptive Statistics (n = 9)
n

Minimum

Maximum

Mean

Std.
Deviation

BMI

9

23.01

46.80

32.8467

7.10511

Depression

9

10.00

33.00

20.3333

9.24662
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Without participant 10’s data, the BMI and CES-D scores for the remaining nine
participants were positively correlated (r = 0.294). An r of 0.294 indicates a low
correlation between body mass and depression. Table V provides results for Pearson’s r
correlation excluding participant 10’s BMI and CES-D scores (n = 9).
Table V
Correlations (n = 9)

BMI Pearson Correlation

BMI

Depression

1

0.294

BMI Sig. (2-tailed)
Depression Pearson

0.442
0.294

Correlation
Depression Sig. (2-tailed)

0.442

21
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Chapter V
Discussion
Findings
The current study found that five of the participants were experiencing clinically
significant depressive symptoms (CES-D score > 16), which indicates a prevalence of
depression among participants. Previously, it has been reported that about 14–67% of
women with PCOS suffer from depression (Dokras, Clifton, Futterweit, & Wild, 2011).
Therefore, the 50% rate of depression among this sample was expected.
With the inclusion of participant 10’s data, the finding that body mass and
depression were negatively correlated does not reflect the findings of past research. In
women with PCOS, body mass and depression have been found by researchers to be
positively correlated (Barry et al., 2011). According to the current study’s findings
including participant 10, a woman with an obese body mass has a lesser risk of being
depressed than a woman with a normal body mass. This finding also conflicts with the
findings of studies that have evaluated the relationship between body mass and
depression in the general population (Zhao et al., 2009).
Considering participant 10’s outlier value for BMI (BMI = 62.02) as well as her
outlier value for depression (CES-D = 8), she may have provided too much variability for
such a small sample population (n = 10), thus skewing results. To test this conjecture, the
data was analyzed without using participant 10’s data.
Excluding participant 10’s data, the results indicated a positive correlation
between body mass and depression (r = 0.294). These results were congruent with the
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findings of past research (Barry et al., 2011). Furthermore, the results indicated a
moderate relationship between body mass and depression.
The findings of this study are conflicting. In the current study p > 0.05.
Therefore, the results are not clinically significant. However, it is recommended that
healthcare providers screen all women with PCOS from Mississippi for depression. Past
research as well as the current study found that a correlation between body mass and
depression does exist in women with PCOS so healthcare providers should not ignore
patients’ psychological health. If depression is identified and treated, a woman’s PCOS
outcome might be improved (Katon & Ciechhanowski, 2002).
Limitations and Cautions
Limitations to this study include a small sample size. The results and conclusions
of this study may not be suitable for generalization. Because of the low response rate,
women with chronic diseases other than PCOS were included in this study. Due to the
fact that chronic disease contributes to depression, the results may have been skewed.
The current study is limited due to the fact that individuals without access to the
Internet are not represented.

Because personal information was requested over the

Internet (full name and email address), the response rate may have been negatively
affected (Jeavons, 2000).
Recommendations for Future Study
The current study aimed to evaluate the relationship between body mass and
depression in Mississippi women with PCOS. Future research could be conducted to
examine cause and effect. Other factors that might contribute to depression in
Mississippi women with PCOS including less education, nonprofessional occupations,
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smoking history, and taking hormones, could be investigated (Cipkala-Gaffin, Talbott,
Song, Bromberger and Wilson, 2012). Future research needs to be conducted with a
larger sample to further examine the relationship between body mass and depression in
Mississippi women with PCOS.
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Appendix A

THE UNIVERSITY OF SOUTHERN MISSISSIPPI
AUTHORIZATION TO PARTICIPATE IN RESEARCH
PROJECT
Consent is hereby given to participate in the study titled:
Body Mass and Depression among Mississippi Women with PCOS
1. Purpose: Thank you for your interest in this research. This study is being done

to investigate a possible relationship between body mass and depression among
Mississippi women with polycystic ovarian syndrome (PCOS). This study is
being performed to fulfill a thesis requirement for graduation from the Honors
College of the Univeristy of Southern Mississippi. The results of this study will
be published by the University of Southern Mississippi. The results may be
published or presented elsewhere in an academic setting.
2. Description of Study: Participation involves filling out a 25 question survey

that takes no more than 20 minutes to complete. 20 of the 25 questions are
multiple choice and include questions about your emotions and lifestyle. The
5 remaining questions ask you to fill out demographic information as well as
height and weight. The survey answers will be kept confidential and the
answers will only be used for this thesis study. You do not have to answer
questions that make you uncomfortable. If you change your mind about
participation while taking the survey, you may exit the survey by closing the
browser window.
3. Benefits: There is no compensation for completion of this study, but

know that by participating in this study you will be contributing to
existing and future research about PCOS and how it affects mental
health.
4. Risks: Risks include an increased awareness of your mental state, particularly a

state of depression. If this happens to you, you should immediately contact a
national crisis hotline such as the United Way Helpline (1-800-233-HELP), or a
national suicide crisis hotline such as the National Hopeline Center (1-800-7842433), and/or your healthcare provider. If you are in a medical emergency or a
suicidal crisis please call 911. The University of Southern Mississippi has no
mechanism to provide compensation for participants who may incur injuries as a
result of participating in research projects. However, efforts will be made to
make available the facilities and professional skills at the University.
5. Confidentiality: The following steps will be taken to keep information about

you confidential and to protect it from unauthorized disclosure: Survey
answers will be password protected on the researcher’s Qualtrics.com account.
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Only the researcher can access this information. When transferring the survey
answers to a spreadsheet for data analysis, any identifying information will be
excluded (such as your full name). Any identifying information will only be
accessible by the researcher through the password protected Qualtrics.com
account. Only survey answers will be used in the written thesis. Any
identifying information will not be used in the thesis. Answers will be kept
confidential. Likewise, any identifying information will be kept confidential.
If you choose to email the researcher or the researcher’s supervisor, your
identifying information will not be released to anyone, and the emails will be
promptly deleted after each correspondence. After publication of the thesis all
data will be deleted from the researcher’s computer and the researcher’s
qualtrics.com account will be deactivated.
6. Participant's Assurance: Whereas no assurance can be made concerning

results that may be obtained (since results from investigational studies
cannot be predicted) the researcher will take every precaution consistent
with the best scientific practice. Participation in this project is completely
voluntary, and participants may withdraw from this study at any time
without penalty, prejudice, or loss of benefits.
7. Questions? Questions concerning the research should be directed to the

researcher, Laurel Bruce at laurel.bruce@eagles.usm.edu or to the
researcher’s supervisor at Elizabeth.Tinnon@.usm.edu. This project and
this consent form have been reviewed by the Institutional Review Board,
which ensures that research projects involving human subjects follow
federal regulations. Any questions or concerns about rights as a research
participant should be directed to the Chair of the Institutional Review
Board, The University of Southern Mississippi, 118 College Drive #5116,
Hattiesburg, MS 39406-0001, (601) 266-5997. A copy of this form will be
given to the participant.
8. Signatures: In conformance with the federal guidelines, the signature of the

participant must appear on all written consent documents.
_______________________________

____________________

Signature of Research Participant

Date

Please list an email address below so that you can receive a follow-up email from
the researcher if you score as being at risk for depression:
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Additional Survey Questions

1. List your height:
2. List your weight:
3. Have you been diagnosed with a medical condition/conditions other than PCOS? If so
please list it here:
4. Select your age:
a. 21-34 years
b. 35-44 years
c. 45-54 years
d. 54+ years
5. Select your race:
a. Hispanic or Latino
b. American Indian or Native Alaskan
c. Asian
d. Black or African American
e. Native Hawaiian or Other Pacific Islander
f. White or Caucasian
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Appendix D
Recruitment Document
I, Laurel Bruce, am an undergraduate nursing student at the University of
Southern Mississippi seeking participants for a thesis study investigating body mass and
depression among Mississippi women with polycystic ovarian syndrome (PCOS).
Participation involves filling out a 25 question online survey that should take no more
than 20 minutes of your time. To participate you must be 18 or older, you must have
received a diagnosis of PCOS from a gynecologist or endocrinologist, and you must be a
current resident of the state of Mississippi.
If you agree to participate you will complete the survey at: [hyperlink]. Your survey
answers will be kept confidential, and the answers will only be used for this thesis study.
Any identifying information will not be included in the thesis and will be kept
confidential. You do not have to answer questions that make you uncomfortable. If you
change your mind about participation while taking the survey, you may exit the survey.
The results of this study may be published and/or presented in the academic setting. If
you have any questions or concerns about the study please contact the researcher, Laurel
Bruce, at laurel.bruce@eagles.usm.edu. This research is being conducted under the
supervision of Dr. Elizabeth Tinnon who can be contacted at elizabeth.tinnon@usm.edu.
This project has been reviewed by the Human Subjects Protection Review Committee,
which ensures that research projects involving human subjects follow federal regulations.
Any questions or concerns about rights as a research subject should be directed to the
Chair of the Institutional Review Board, The University of Southern Mississippi, 118
College Drive #5147, Hattiesburg, MS 39406-0001, (601) 266-6820.
Thank you for your consideration,
Laurel Bruce
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